Dronabinol improves chronic non-cancer pain when added to standard opioid therapy
Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid TherapyJ Pain. 2008 Mar;9(3):254-64
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
30 chronic pain patients who were on stable doses of opioids received a single dose of each of10 mg of dronabinol (a synthetic cannabinoid), 20 mg dronabinol, or placebo in a random order, followed by 4 weeks of 5-60 mg dronabinol (open-label). The primary outcome was total pain relief at 8 hours in the randomized phase and change in pain intensity on a numeric rating scale (NRS) in the open-labe...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue